1017 related articles for article (PubMed ID: 17457367)
1. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
2. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
Schneider A; Krüger C; Steigleder T; Weber D; Pitzer C; Laage R; Aronowski J; Maurer MH; Gassler N; Mier W; Hasselblatt M; Kollmar R; Schwab S; Sommer C; Bach A; Kuhn HG; Schäbitz WR
J Clin Invest; 2005 Aug; 115(8):2083-98. PubMed ID: 16007267
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model.
Nakagawa T; Suga S; Kawase T; Toda M
Brain Res; 2006 May; 1089(1):179-85. PubMed ID: 16678804
[TBL] [Abstract][Full Text] [Related]
5. Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation.
Kong T; Choi JK; Park H; Choi BH; Snyder BJ; Bukhari S; Kim NK; Huang X; Park SR; Park HC; Ha Y
J Neurosurg; 2009 Jul; 111(1):155-63. PubMed ID: 19361262
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins.
Huang X; Choi JK; Park SR; Ha Y; Park H; Yoon SH; Park HC; Park JO; Choi BH
Neurosci Res; 2007 May; 58(1):50-7. PubMed ID: 17331604
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines.
Helftenbein G; Krusekopf K; Just U; Cross M; Ostertag W; Niemann H; Tamura T
Oncogene; 1996 Feb; 12(4):931-5. PubMed ID: 8632916
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats.
Wang HY; Wang GL; Yu YH; Wang Y
Brain Res; 2009 Nov; 1297():177-84. PubMed ID: 19703434
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia.
Lee ST; Chu K; Jung KH; Ko SY; Kim EH; Sinn DI; Lee YS; Lo EH; Kim M; Roh JK
Brain Res; 2005 Oct; 1058(1-2):120-8. PubMed ID: 16150422
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway.
Choi JK; Kim KH; Park H; Park SR; Choi BH
Apoptosis; 2011 Feb; 16(2):127-34. PubMed ID: 21052840
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
12. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
Pitzer C; Klussmann S; Krüger C; Letellier E; Plaas C; Dittgen T; Kirsch F; Stieltjes B; Weber D; Laage R; Martin-Villalba A; Schneider A
J Neurochem; 2010 May; 113(4):930-42. PubMed ID: 20202082
[TBL] [Abstract][Full Text] [Related]
13. Regulation of myeloid development and function by colony stimulating factors.
Barreda DR; Hanington PC; Belosevic M
Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro.
Zhang L; Qu Y; Tang J; Chen D; Fu X; Mao M; Mu D
Brain Res; 2010 Oct; 1357():157-65. PubMed ID: 20705061
[TBL] [Abstract][Full Text] [Related]
15. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways.
Chen WF; Jean YH; Sung CS; Wu GJ; Huang SY; Ho JT; Su TM; Wen ZH
Neuroscience; 2008 Apr; 153(1):31-43. PubMed ID: 18358629
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1.
Klampfer L; Zhang J; Nimer SD
Cytokine; 1999 Nov; 11(11):849-55. PubMed ID: 10547272
[TBL] [Abstract][Full Text] [Related]
17. Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells.
Lee AW; States DJ
Cell Death Differ; 2006 Nov; 13(11):1900-14. PubMed ID: 16514418
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
[TBL] [Abstract][Full Text] [Related]
19. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor in murine macrophage cell line J774A.1.
Fan K; Barendsen N; Sensenbrenner L; Chen BD
J Cell Physiol; 1993 Mar; 154(3):535-42. PubMed ID: 8436602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
